AUSTIN, Texas, Nov. 25, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Harriss Currie, Senior Vice President of Finance and CFO, will participate in investor meetings and present at the Piper Jaffray 31st Annual Healthcare Conference on Wednesday, December 4, 2019 in New York, NY. A live webcast of Luminex’s presentation will be available... Read more
AUSTIN, Texas, Nov. 4, 2019 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2019. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”). Comparisons shown in this release are to the same period in the prior year unless otherwise noted. CURRENT... Read more
AUSTIN, Texas, Oct. 25, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2019 on Monday, November 4, 2019 after the market close. The company will host a conference call that day at 5:00 p.m. Eastern Time to discuss operating highlights and financial... Read more
AUSTIN, Texas, Oct. 1, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced that the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ARIES® MRSA Assay. The assay is an integrated, real-time, polymerase chain reaction (PCR) based, qualitative, in vitro diagnostic test for the direct detection of methicillin-resistant Staphylococcus aureus (MRSA)... Read more
AUSTIN, Texas, Sept. 26, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President and Chief Executive Officer, and Harriss Currie, Senior Vice President of Finance and CFO, will participate in investor meetings and present at the Cantor Global Healthcare Conference on Wednesday, October 2, 2019 in New York, NY. A live... Read more
AUSTIN, Texas, Sept. 3, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Morgan Stanley 17th Annual Global Healthcare Conference to be held September 9-11, 2019, in New York, NY. The fireside chat will begin at 2:05 p.m. Eastern... Read more
AUSTIN, Texas, July 31, 2019 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced financial results for the second quarter 2019. Financial and operating highlights for the quarter include: Second quarter consolidated revenue increased 4% to $83.1 million from $79.6 million in the second quarter 2018. Flow cytometry contributed revenue of approximately $13.2 million, or 16% of... Read more
AUSTIN, Texas, July 11, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2019 on Wednesday, July 31, 2019. A press release announcing the results is scheduled for release after the close of trading on that date. Management will hold a conference... Read more
AUSTIN, Texas, July 1, 2019 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced that the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration (FDA) for clearance on Friday, June 28, 2019. The assay is a qualitative polymerase chain reaction (PCR)-based, in vitro diagnostic test for the direct detection of methicillin-resistant Staphylococcus aureus... Read more
AUSTIN, Texas, May 21, 2019 /PRNewswire/ — Luminex Corporation (Nasdaq:LMNX) (the “Company”), today announced that its board of directors declared a cash dividend for the second quarter of 2019 of $0.06 per share of common stock payable on July 11, 2019 to stockholders of record as of the close of business June 20, 2019. About Luminex CorporationAt... Read more